Stocks & Indices Unverified First seen 2026-10-12 13:33 UTC

Bristol Myers reports two Phase 3 wins; rival stock falls

Investor's Business Daily reported that Bristol Myers Squibb scored two Phase 3 wins on Monday in lung disease and cancer. The post states the stock rose while a key rival plummeted, without naming the rival or giving figures.

Why “Unverified”

Reported by Investor's Business Daily alone, with no second source or primary confirmation yet

1 independent source group across 1 post · evidence score 52/100. How labels work

What the sources claim

Bristol Myers Squibb scored two Phase 3 wins on Monday in lung disease and cancer.

“Bristol Myers Squibb scored two Phase 3 wins on Monday in lung disease and cancer.”
Investor's Business Daily
Bristol Myers stock rose while a key rival plummeted.

“The stock rose, while a key rival plummeted.”
Investor's Business Daily

Sources

Investor's Business Daily newswire 2026-10-12 13:33 UTC
Bristol Myers Scores Two Phase 3 Wins, But A Key Rival Plummets On One

More in Stocks & Indices

All Stocks & Indices stories →

Summary and claims extracted by AI with prompt analyze-story@5 on 2026-10-12 13:40 UTC. Labels are computed from the sources, not by the model.